Roche Diagnostics, Boehringer Mannheim Liquid Total Bilirubin Reagent
Diazo Colorimetry, Bilirubin. 510(k) K981632, from Roche Diagnostics/Boehringer Mannheim GmbH (Indianapolis, IN). Product code CIG, class 2.
As of Nov 19, 2026, K981632 is an FDA 510(k) held by Roche Diagnostics/Boehringer Mannheim GmbH, substantially equivalent on Jun 15, 1998 after 38 days, with no recalls tied to it in FDA's recall database.
- Review time: 38 days
- Recalls: 0
- Cited as a predicate by: 4 devices
The Roche Diagnostics, Boehringer Mannheim Liquid Total Bilirubin reagent is intended for use for the quantitative determination of total bilirubin in serum and plasma of adults and neonates. It is for use on automated clinical chemistry analyzers.
- Bilirubin, Dingle Valve DpdK781921 · Boehringer Mannheim Corp. · Jan 3, 1979
- Cobas C Bilirubin Total GEN.3K131544 · Roche Diagnostics · Jul 17, 2013
- Cobas Integra C 111K063744 · Rochdiag · Jan 17, 2007
- Cobas Integra Bilirubin Special and Roche/Hitachi Bilrubin Total, Models 20737496 322, 03261638 190, and 11822713 226K063543 · Roche Diagnostics Corp. · Dec 22, 2006
- Bilirubin Assay On The Omni S AnalyzerK040174 · Roche Diagnostics Corp. · May 14, 2004
- Atellica CH Diazo Total Bilirubin (D_TBil)K251998 · Siemens Healthcare Diagnostics, Inc. · Feb 27, 2026
- Atellica® CH Diazo Direct Bilirubin (D_DBil)K223078 · Siemens Healthcare Diagnostics, Inc. · Jun 12, 2023
- Atellica® CH Diazo Total Bilirubin (D_TBil)K222104 · Siemens Healthcare Diagnostics, Inc. · Mar 20, 2023
- Total Bilirubin2K223324 · Abbott Ireland Diagnostics Division · Dec 29, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 8, 1998
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1110
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files